New guidelines for COVID vaccine. Prior to the new guidelines, it was recommended that everyone who is 6 months and older get ...

Agency will ask drugmakers for large trials for new versions of vaccines meant for healthy adults and children.

The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new ...

The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the ...

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.

In a major policy shift, federal health officials anticipate the shots will be made available to adults 65 and older as well ...

"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...

The FDA said moving forward, it will adopt a framework requiring proof that a vaccine can generate antibodies in people over ...

Agency leaders said there was evidence to justify approval only for older people and those with medical conditions. Many ...

"Here is a prime example of just how influential Big Pharma still is," MAHA influencer Diana Atieh told Newsweek.

The U.S. Food and Drug Administration plans to require new clinical trials for approval of annual COVID-19 boosters for ...